BioSpace News Archive

CereScan’s Littleton, Colorado Facility Is an Approved Site for the SPARC Phase 2 Clinical Trial

Series B participants led by Foresite Capital with additional new investors Bain Capital Life Sciences, venBio Partners, and Venrock Partners

The Lasker Foundation today announced the winners of its 2019 Lasker Awards

Lung cancer screening model favored in Europe detects more cancers than one preferred in the United States

With more than 3,500 events worldwide the Relay For Life movement continues to be the largest peer-to-peer fundraising event to achieve a world without cancer

DrFirst is first to offer mobile-enabled, real-time document e-signature for patients and providers, protecting patient safety and reducing care delays

Kindred Biosciences, Inc. announced that it has been selected by the National Cancer Institute as one of three contractors in response to the solicitation for the PREVENT Cancer Preclinical Drug Development Program: Current Good Manufacturing Practice Production of Vaccines and Biologicals for Cancer Prevention.

Biotech startup Opentrons creates even more lab technology to help biologists take advantage of lab automation, regardless of cost

Industry comes together to advance product development and stay ahead of changing regulations

Research published in the journal BLOOD ADVANCES established the feasibility of using a small bank of third-party cell lines generated from carefully chosen donors to provide virus-specific T-cell therapy to a large number of patients.